173 related articles for article (PubMed ID: 22723173)
1. [Development of therapeutic antibodies for gastric and colorectal cancers].
Zhao TT; Fan NN; Lin L; Din Q; Zhan JB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 May; 41(3):345-52. PubMed ID: 22723173
[TBL] [Abstract][Full Text] [Related]
2. Development of antibodies and chimeric molecules for cancer immunotherapy.
Waldmann TA; Morris JC
Adv Immunol; 2006; 90():83-131. PubMed ID: 16730262
[TBL] [Abstract][Full Text] [Related]
3. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for gastrointestinal malignancies.
Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Antibodies in Cancer Therapy.
Gasser M; Waaga-Gasser AM
Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Possible applications of antibodies or their genes in cancer therapy.
Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.
Bilgin B; Sendur MA; Bülent Akıncı M; Şener Dede D; Yalçın B
Curr Med Res Opin; 2017 Apr; 33(4):749-759. PubMed ID: 28055269
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors in the Treatment of Gastrointestinal Malignancies: A Review of Current and Future Therapies.
Hsu A; Mendelson L; Almhanna K
R I Med J (2013); 2020 Apr; 103(3):33-37. PubMed ID: 32236159
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma.
Sears HF; Herlyn D; Steplewski Z; Koprowski H
J Biol Response Mod; 1984; 3(2):138-50. PubMed ID: 6374043
[TBL] [Abstract][Full Text] [Related]
11. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers.
Hwang K; Yoon JH; Lee JH; Lee S
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466394
[TBL] [Abstract][Full Text] [Related]
13. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
Nazha B; Inal C; Owonikoko TK
Front Oncol; 2020; 10():1000. PubMed ID: 32733795
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal cancer: recent developments in medical oncology.
Chong G; Cunningham D
Eur J Surg Oncol; 2005 Jun; 31(5):453-60. PubMed ID: 15922879
[TBL] [Abstract][Full Text] [Related]
15. New approaches to antibody therapy.
Weiner LM; Adams GP
Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy.
O'Mahony D; Bishop MR
Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
[TBL] [Abstract][Full Text] [Related]
17. Trends in therapeutic monoclonal antibodies of cancer.
Shi W; Qu C; Qian Q
Expert Opin Ther Pat; 2007 Sep; 17(9):1047-59. PubMed ID: 20144085
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies in the treatment of cancer.
Dillman RO
Crit Rev Oncol Hematol; 1984; 1(4):357-85. PubMed ID: 6397268
[TBL] [Abstract][Full Text] [Related]
19. Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications.
Shin C; Kim SS; Jo YH
Mol Ther Oncolytics; 2021 Sep; 22():166-179. PubMed ID: 34514097
[TBL] [Abstract][Full Text] [Related]
20. Antibody-based therapy in colorectal cancer.
Noguchi T; Ritter G; Nishikawa H
Immunotherapy; 2013 May; 5(5):533-45. PubMed ID: 23638747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
